210 related articles for article (PubMed ID: 18095117)
1. Comparison of 1H-MRS-detected metabolic characteristics in single metastatic brain tumors of different origin.
Chernov MF; Ono Y; Kubo O; Hori T
Brain Tumor Pathol; 2006 Apr; 23(1):35-40. PubMed ID: 18095117
[TBL] [Abstract][Full Text] [Related]
2. Metabolic characteristics of intracranial metastases, detected by single-voxel proton magnetic resonance spectroscopy, are seemingly not predictive for tumor response to gamma knife radiosurgery.
Chernov M; Hayashi M; Izawa M; Nakaya K; Ono Y; Usukura M; Yoshida S; Kato K; Muragaki Y; Nakamura R; Iseki H; Hori T; Takakura K
Minim Invasive Neurosurg; 2007 Aug; 50(4):233-8. PubMed ID: 17948183
[TBL] [Abstract][Full Text] [Related]
3. Metabolic alterations in the peritumoral brain in cases of meningiomas: 1H-MRS study.
Chernov MF; Nakaya K; Kasuya H; Kato K; Ono Y; Yoshida S; Nakamura R; Suzuki T; Muragaki Y; Iseki H; Kubo O; Hori T; Takakura K
J Neurol Sci; 2009 Sep; 284(1-2):168-74. PubMed ID: 19497588
[TBL] [Abstract][Full Text] [Related]
4. Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.
Chernov MF; Hayashi M; Izawa M; Usukura M; Yoshida S; Ono Y; Muragaki Y; Kubo O; Hori T; Takakura K
Brain Tumor Pathol; 2006 Apr; 23(1):19-27. PubMed ID: 18095115
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of the radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases: importance of multi-voxel proton MRS.
Chernov M; Hayashi M; Izawa M; Ochiai T; Usukura M; Abe K; Ono Y; Muragaki Y; Kubo O; Hori T; Takakura K
Minim Invasive Neurosurg; 2005 Aug; 48(4):228-34. PubMed ID: 16172969
[TBL] [Abstract][Full Text] [Related]
6. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.
Chernov MF; Hayashi M; Izawa M; Ono Y; Hori T
Int J Clin Oncol; 2006 Oct; 11(5):375-84. PubMed ID: 17058135
[TBL] [Abstract][Full Text] [Related]
8. Differences in metabolic and morphological reactions after radiation therapy: proton NMR spectroscopy and imaging of patients with intracranial tumors.
Ikehira H; Miyamoto T; Yasukawa T; Obata T; Katoh H; Koga M; Yoshikawa K; Yoshida K; Tateno Y
Radiat Med; 1995; 13(5):199-204. PubMed ID: 8848553
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T.
Sjøbakk TE; Johansen R; Bathen TF; Sonnewald U; Kvistad KA; Lundgren S; Gribbestad IS
BMC Cancer; 2007 Jul; 7():141. PubMed ID: 17662122
[TBL] [Abstract][Full Text] [Related]
10. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
11. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy.
Palumbo B; Lupattelli M; Pelliccioli GP; Chiarini P; Moschini TO; Palumbo I; Siepi D; Buoncristiani P; Nardi M; Giovenali P; Palumbo R
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208
[TBL] [Abstract][Full Text] [Related]
12. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
Gajewicz W; Papierz W; Szymczak W; Goraj B
Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
[TBL] [Abstract][Full Text] [Related]
13. [Sequential observations of brain edema with proton magnetic resonance imaging and spectroscopy].
Kamada K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):105-22. PubMed ID: 8727379
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas.
Morales H; Kwock L; Castillo M
J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777
[TBL] [Abstract][Full Text] [Related]
15. 1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors.
Sijens PE; Levendag PC; Vecht CJ; van Dijk P; Oudkerk M
NMR Biomed; 1996 Apr; 9(2):65-71. PubMed ID: 8887370
[TBL] [Abstract][Full Text] [Related]
16. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
17. Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies.
Tzika AA; Astrakas L; Cao H; Mintzopoulos D; Andronesi OC; Mindrinos M; Zhang J; Rahme LG; Blekas KD; Likas AC; Galatsanos NP; Carroll RS; Black PM
Int J Mol Med; 2007 Aug; 20(2):199-208. PubMed ID: 17611638
[TBL] [Abstract][Full Text] [Related]
18. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial.
Negendank W; Sauter R
Anticancer Res; 1996; 16(3B):1533-8. PubMed ID: 8694522
[TBL] [Abstract][Full Text] [Related]
20. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
Wald LL; Nelson SJ; Day MR; Noworolski SE; Henry RG; Huhn SL; Chang S; Prados MD; Sneed PK; Larson DA; Wara WM; McDermott M; Dillon WP; Gutin PH; Vigneron DB
J Neurosurg; 1997 Oct; 87(4):525-34. PubMed ID: 9322843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
